{
    "relation": [
        [
            "",
            "Ever Smoked Cigarettes: NO",
            "Ever Smoked Cigarettes: YES"
        ],
        [
            "Description",
            "Subjects who have never smoked cigarettes",
            "Subjects who have smoked cigarettes"
        ]
    ],
    "pageTitle": "Effectiveness of Two Hepatitis B Vaccines in HIV-negative Youths - Study Results - ClinicalTrials.gov",
    "title": "",
    "url": "https://clinicaltrials.gov/ct2/show/results/NCT00107042?sect=Xl0156&view=results",
    "hasHeader": true,
    "headerPosition": "MIXED",
    "tableType": "RELATION",
    "tableNum": 25,
    "s3Link": "common-crawl/crawl-data/CC-MAIN-2015-32/segments/1438042990114.79/warc/CC-MAIN-20150728002310-00260-ip-10-236-191-2.ec2.internal.warc.gz",
    "recordEndOffset": 872936285,
    "recordOffset": 872920346,
    "tableOrientation": "VERTICAL",
    "textBeforeTable": "Reporting Groups No text entered. Significant events and approaches for the overall study following participant enrollment, but prior to group assignment Pre-Assignment Details The study was started in February 2004 and was completed in July 2008. A total of 11 sites, all in the United States and Puerto Rico, participated in the study. Key information relevant to the recruitment process for the overall study, such as dates of the recruitment period and locations Recruitment Details \u00a0 Hide Participant Flow \u00a0 Participant Flow Biological: Recombivax Biological: Twinrix Interventions: Hepatitis B Condition: Allocation:\u00a0Randomized; \u00a0 Endpoint\u00a0Classification:\u00a0Safety/Efficacy\u00a0Study; \u00a0 Intervention\u00a0Model:\u00a0Parallel\u00a0Assignment; \u00a0 Masking:\u00a0Single\u00a0Blind\u00a0(Subject); \u00a0 Primary\u00a0Purpose:\u00a0Prevention Study Design: Interventional Study Type:",
    "textAfterTable": "Participant Flow: \u00a0 Overall Study \u00a0 \u00a0 Recombivax \u00a0 \u00a0 Twinrix \u00a0 STARTED \u00a0 \u00a0 60 \u00a0 \u00a0 63 \u00a0 COMPLETED \u00a0 \u00a0 38 \u00a0 \u00a0 47 \u00a0 NOT COMPLETED \u00a0 \u00a0 22 \u00a0 \u00a0 16 \u00a0 Lost to Follow-up \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 9 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 7 \u00a0 Withdrawal by Subject \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 6 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 1 \u00a0 Moved out of area \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 5 \u00a0",
    "hasKeyColumn": true,
    "keyColumnIndex": 0,
    "headerRowIndex": 0
}